A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based...
New Treatments for Parkinson’s Disease | APDA
Oct 19, 2021 · Exploring seven recently approved Parkinson’s treatments. Update: View our updated post of new Parkinson’s treatments in the clinical trial pipeline for 2023 and 2024. Remarkably, in the last five years, seven new medications have been approved for the treatment of the motor symptoms of Parkinson’s disease (PD), with two approved in 2020 ...
New Parkinson’s Treatments in the Clinical Trial Pipeline for 2024
Sep 26, 2023 · Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
When will there be a cure for Parkinson's? | Parkinson's UK
There’s currently no cure for Parkinson’s. We're pushing to deliver new treatments for Parkinson's in years, not decades. And we're determined to develop a cure in the shortest possible time.
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
Mar 11, 2024 · A novel immunotherapy candidate, UB-312, produced by Vaxxinity, targets and clears toxic clumps of alpha-synuclein, a protein linked to Parkinson's disease. The trial on 20 patients showed a 20 percent drop in alpha-syn levels and improved movements, offering hope for a disease-modifying treatment.
New Parkinson’s drug could slow or reverse progression of …
Aug 21, 2024 · A new drug for Parkinson’s disease showed promising results in a safety and tolerability study, according to researchers. Michael Okun, M.D., director of the Norman Fixel Institute at UF Health, cautioned that more research is …
Novel cell therapy continues to show promise for Parkinson's …
Mar 6, 2024 · Orange, Calif. — New clinical trial data for bemdaneprocel, a promising stem cell-derived therapy for Parkinson’s disease, continues to show positive results 18 months after treatment, scientists reported today at an international conference in Portugal.
Parkinson's Discovery Suggests We May Already Have an FDA …
A new study reveals how a protein called Aplp1 helps alpha-synuclein clumps spread in brain cells and suggests a cancer drug that targets another protein called Lag3 could block the process. The research could lead to a potential therapy for Parkinson's disease and other neurodegenerative diseases.
Breakthrough Parkinson’s Treatment Enters Human Trials
Aug 7, 2024 · A clinical trial has begun to offer a new treatment to people with Parkinson’s disease, following a study by University of Wisconsin–Madison scientists. This study, conducted on non-human primates, confirmed that the therapeutic delivery method is safe and feasible.
Promising Parkinson’s therapy gets FDA investigational nod
Jun 6, 2024 · A cellular therapy to treat Parkinson's disease is given Regenerative Medicine Advanced Therapy designation by the U.S. Food and Drug Administration, putting it on a fast track for review.
- Some results have been removed